Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.0056 | 1 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |